Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder.
about
Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cost-effectiveness of subderma ...... to treat opioid use disorder.
@en
type
label
Cost-effectiveness of subderma ...... to treat opioid use disorder.
@en
prefLabel
Cost-effectiveness of subderma ...... to treat opioid use disorder.
@en
P2860
P1476
Cost-effectiveness of subderma ...... e to treat opioid use disorder
@en
P2093
Michael Frost
Ryan Dammerman
P2860
P304
P356
10.1080/13696998.2017.1341416
P407
P577
2017-06-22T00:00:00Z